Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fraken Biochem is a specialized manufacturer of high-value active pharmaceutical ingredients (APIs) and biochemicals, with a primary focus on immunosuppressants and Vitamin D derivatives. Based in Zhejiang, China, the company produces a range of critical products including Mycophenolate Mofetil, Tacrolimus, and Sirolimus, as well as Vitamin D analogs like Calcitriol and Alfacalcidol. Their manufacturing facilities are designed to meet international quality standards, having received certifications such as GMP and successful inspections from the US FDA and EDQM. Fraken Biochem leverages advanced fermentation and chemical synthesis technologies to serve the global pharmaceutical market. The company is a key supplier for treatments in therapeutic areas such as immunology, endocrinology, and nephrology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fraken Biochem.